AFEYAN NOUBAR
SEC Form 4 insider trading activity
AFEYAN NOUBAR has filed 4 SEC Form 4 filings (20 transaction rows) across 2 companies, including MRNA, GENB, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, AFEYAN NOUBAR is listed as Director at Moderna, Inc. Inside the rolling window, AFEYAN NOUBAR reported 1 open-market purchase totaling $25.0M in GENB and 2 open-market sales totaling $1.1M in MRNA. The largest disclosed transaction in the window is a purchase of 1,562,500 GENB shares on Mar 2, 2026, worth $25.0M.
Companies traded
Other insiders at MRNA
Insider Buying
$25.0M
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has AFEYAN NOUBAR made?
AFEYAN NOUBAR has filed 4 SEC Form 4 filings (20 transaction rows) across 2 companies, including MRNA, GENB since 2025.
Which companies does AFEYAN NOUBAR trade?
AFEYAN NOUBAR has filed SEC Form 4 disclosures for 2 companies, including MRNA, GENB.
When was AFEYAN NOUBAR's most recent SEC Form 4 filing?
AFEYAN NOUBAR's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is AFEYAN NOUBAR's total buy and sell value in the current window?
Inside the rolling retention window, AFEYAN NOUBAR bought $25.0M and sold $1.1M based on SEC Form 4 filings.
What was AFEYAN NOUBAR's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,562,500 GENB shares on 2026-03-02, worth $25.0M, per SEC Form 4 filings.